Jump to content

Cholinesterase

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by KConWiki (talk | contribs) at 04:15, 22 May 2010 (→‎Pop culture). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Template:FixBunching

acetylcholinesterase (Yt blood group)
Diagram of Pacific electric ray acetylcholinesterase. From PDB: 1EA5​.
Identifiers
SymbolACHE
Alt. symbolsYT
NCBI gene43
HGNC108
OMIM100740
RefSeqNM_015831
UniProtP22303
Other data
EC number3.1.1.7
LocusChr. 7 q22
Search for
StructuresSwiss-model
DomainsInterPro

Template:FixBunching

butyrylcholinesterase
Cartoon diagram of human butyrylcholinesterase. From PDB: 1P0I​.
Identifiers
SymbolBCHE
Alt. symbolsCHE1
NCBI gene590
HGNC983
OMIM177400
RefSeqNM_000055
UniProtP06276
Other data
EC number3.1.1.8
LocusChr. 3 q26.1-26.2
Search for
StructuresSwiss-model
DomainsInterPro

Template:FixBunching In biochemistry, cholinesterase is a family of enzymes that catalyze the hydrolysis of the neurotransmitter acetylcholine into choline and acetic acid, a reaction necessary to allow a cholinergic neuron to return to its resting state after activation.

Types

There are two types:

The difference between the two types of cholinesterase has to do with their respective preferences for substrates: the former hydrolyses acetylcholine more quickly; the latter hydrolyses butyrylcholine more quickly.

History

In 1968, Walo Leuzinger et al. successfully purified and crystallized the enzyme from electric eels at Columbia University, NY.[1][2]

The 3D structure of acetylcholinesterase was first determined in 1991 by Joel Sussman et al. using protein from the Pacific electric ray.[3]

Clinically-useful quantities of butyrylcholinesterase were synthesized in 2007 by PharmAthene, through the use of genetically-modified goats.[4]

Clinical significance

An absence or mutation of the pseudocholinesterase enzyme leads to a medical condition known as pseudocholinesterase deficiency. This is a silent condition that manifests itself only when people that have the deficiency receive the muscle relaxants succinylcholine or mivacurium during a surgery.

Pseudocholinesterase deficiency may also affect local anaesthetic selection in dental procedures. The enzyme plays an important role in the metabolism of ester-based local anaesthetics, a deficiency lowers the margin of safety and increases the risk of systemic effects with this type of anaesthetic. The selection of an amide-based solution is recommended in such patients.

Elevation of plasma pseudocholinesterase was observed in 90.5% cases of acute myocardial infarction.[5]

The presence of acetylcholinesterase in the amniotic fluid may be tested in early pregnancy. A sample of amniotic fluid is removed by amniocentesis, and presence of AChE can confirm several common types of birth defect, including abdominal wall defects and neural tube defects.[6]

Butyrylcholinesterase can be used as a prophylactic agent against nerve gas and other organophosphate poisoning.[4]

Cholinesterase inhibitors

A cholinesterase inhibitor (or "anticholinesterase") suppresses the action of the enzyme. Because of its essential function, chemicals that interfere with the action of cholinesterase are potent neurotoxins, causing excessive salivation and eye-watering in low doses, followed by muscle spasms and ultimately death (examples are some snake venoms, and the nerve gases sarin and VX). One counteracting medication is pralidoxime.

Among the most common acetylcholinesterase inhibitors are phosphorus-based compounds, which are designed to bind to the active site of the enzyme. The structural requirements are a phosphorus atom bearing two lipophilic groups, a leaving group (such as a halide or thiocyanate), and a terminal oxygen. The entry on Lawesson's reagent has some details on one sub-class of the phosphorus-based compounds.

Benzodiazepines, eg temazepam have an inhibitory effect on cholinesterase.[7]

Outside of biochemical warfare, anticholinesterases are also used for reversing medication induced paralysis during anesthesia; as well as in the treatment of myasthenia gravis, glaucoma, and Alzheimer's disease. Such compounds are used for killing insects in a range of products including sheep dip, organophosphate pesticides, and carbamate pesticides. In addition to acute poisoning as described above, a semi-acute poisoning characterized by strong mental disturbances can occur. Also, prolonged exposure can cause birth defects.

Pop culture

Additional images

References

  1. ^ Leuzinger W, Baker AL (1967). "Acetylcholinesterase, I. Large-scale purification, homogeneity, and amino acid analysis". Proc. Natl. Acad. Sci. U.S.A. 57 (2): 446–451. PMC 335526. PMID 16591490. {{cite journal}}: Unknown parameter |month= ignored (help)
  2. ^ Leuzinger W, Baker AL, Cauvin E (1968). "Acetylcholinesterase. II. Crystallization, absorption spectra, isoionic point". Proc. Natl. Acad. Sci. U.S.A. 59 (2): 620–3. PMC 224717. PMID 5238989. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  3. ^ Sussman JL, Harel M, Frolow F, Oefner C, Goldman A, Toker L, Silman I (1991). "Atomic structure of acetylcholinesterase from Torpedo californica: a prototypic acetylcholine-binding protein". Science. 253 (5022): 872–9. PMID 1678899. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  4. ^ a b Huang YJ, Huang Y, Baldassarre H, Wang B, Lazaris A, Leduc M, Bilodeau AS, Bellemare A, Côté M, Herskovits P, Touati M, Turcotte C, Valeanu L, Lemée N, Wilgus H, Bégin I, Bhatia B, Rao K, Neveu N, Brochu E, Pierson J, Hockley DK, Cerasoli DM, Lenz DE, Karatzas CN, Langermann S (2007). "Recombinant human butyrylcholinesterase from milk of transgenic animals to protect against organophosphate poisoning". Proc. Natl. Acad. Sci. U.S.A. 104 (34): 13603–8. doi:10.1073/pnas.0702756104. PMC 1934339. PMID 17660298. {{cite journal}}: Unknown parameter |laysource= ignored (help); Unknown parameter |laysummary= ignored (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  5. ^ Textbook of Medical Biochemistry, MN Chatterjea & Rana Shinde, 6th Ed, 2005 (Pg 565)
  6. ^ FBR Resource Guide: Acetylcholinesterase-Amniotic Fluid. Foundation for Blood Research (September 7, 2007. Retrieved on 2007-11-21.
  7. ^ Holmes JH (1978). "Effect of benzodiazepine derivatives on human blood cholinesterase in vitro". Res Commun Chem Pathol Pharmacol. 21 (2): 367–70. PMID 29327. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help); Unknown parameter |month= ignored (help)